Literature DB >> 16329186

Immunobiology of human NKG2D and its ligands.

S González1, V Groh, T Spies.   

Abstract

The NKG2D-DAP10 receptor complex activates natural killer (NK) cells and costimulates effector T cell subsets upon engagement of ligands that can be conditionally expressed under physiologically harmful conditions such as microbial infections and malignancies. These characteristics have given rise to the widely embraced concept of immunorecognition of "induced or damaged self," complementing the "missing self" paradigm that is represented by MHC class I allotypes and their interactions with inhibitory receptors on NK cells. However, this notion may only be partially sustainable, as various patterns of constitutive tissue distributions have become apparent among members of one NKG2D ligand family. This review summarizes the biological properties of NKG2D and its ligands and discusses the interactions and regulation of these molecules with emphasis of their significance in microbial infections, tumor immunology, and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16329186     DOI: 10.1007/3-540-27743-9_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  86 in total

1.  Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.

Authors:  Susana Guerra; José Manuel González; Núria Climent; Hugh Reyburn; Luis A López-Fernández; José L Nájera; Carmen E Gómez; Felipe García; José M Gatell; Teresa Gallart; Mariano Esteban
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Evaluation of current cancer immunotherapy: hemato-oncology.

Authors:  Christopher S Hourigan; Hyam I Levitsky
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.

Authors:  B Schilling; E S Halstead; P Schuler; M Harasymczuk; J E Egan; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  2012-01-20       Impact factor: 6.968

Review 4.  Associations between the major histocompatibility complex class I chain-related gene A transmembrane (MICA-TM) polymorphism and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Jae-Hoon Kim; Young Ho Lee
Journal:  Rheumatol Int       Date:  2013-08-22       Impact factor: 2.631

Review 5.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

6.  Identification and Function of MicroRNAs Encoded by Herpesviruses.

Authors:  Zhi-Qiang Bai; Xiu-Fen Lei; Lin-Ding Wang; Shou-Jiang Gao
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

Review 7.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

8.  MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.

Authors:  Masahisa Jinushi; Matthew Vanneman; Nikhil C Munshi; Yu-Tzu Tai; Rao H Prabhala; Jerome Ritz; Donna Neuberg; Kenneth C Anderson; Daniel Ruben Carrasco; Glenn Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

9.  Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.

Authors:  Beatriz M Carreno; Joel R Garbow; Grant R Kolar; Erin N Jackson; John A Engelbach; Michelle Becker-Hapak; Leonidas N Carayannopoulos; David Piwnica-Worms; Gerald P Linette
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

10.  Dissection of spontaneous cytotoxicity by human intestinal intraepithelial lymphocytes: MIC on colon cancer triggers NKG2D-mediated lysis through Fas ligand.

Authors:  Ellen C Ebert; Veronika Groh
Journal:  Immunology       Date:  2008-02-13       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.